Literature DB >> 2184534

Potassium channels and airway function: new therapeutic prospects.

J L Black1, P J Barnes.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2184534      PMCID： PMC462387          DOI： 10.1136/thx.45.3.213

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  51 in total

Review 1.  Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle.

Authors:  T C Hamilton; A H Weston
Journal:  Gen Pharmacol       Date:  1989

Review 2.  The pharmacology of potassium channels and their therapeutic potential.

Authors:  N S Cook
Journal:  Trends Pharmacol Sci       Date:  1988-01       Impact factor: 14.819

3.  Mu-opioid receptors modulate non-cholinergic constrictor nerves in guinea-pig airways.

Authors:  N Frossard; P J Barnes
Journal:  Eur J Pharmacol       Date:  1987-09-23       Impact factor: 4.432

4.  Opioid modulation of non-cholinergic neural bronchoconstriction in guinea-pig in vivo.

Authors:  M G Belvisi; K F Chung; D M Jackson; P J Barnes
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

5.  In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.

Authors:  U Quast; N S Cook
Journal:  J Pharmacol Exp Ther       Date:  1989-07       Impact factor: 4.030

6.  Calcium channel currents in isolated smooth muscle cells from human bronchus.

Authors:  R Marthan; C Martin; T Amédée; J Mironneau
Journal:  J Appl Physiol (1985)       Date:  1989-04

7.  Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line.

Authors:  N C Sturgess; R Z Kozlowski; C A Carrington; C N Hales; M L Ashford
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

8.  Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels.

Authors:  I Cavero; S Mondot; M Mestre
Journal:  J Pharmacol Exp Ther       Date:  1989-03       Impact factor: 4.030

9.  Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat.

Authors:  R E Buckingham; T C Hamilton; D R Howlett; S Mootoo; C Wilson
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

Review 10.  New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma.

Authors:  P J Barnes
Journal:  J Allergy Clin Immunol       Date:  1989-06       Impact factor: 10.793
View more
  12 in total

Review 1.  Recent advances in asthma.

Authors:  P J Barnes; T H Lee
Journal:  Postgrad Med J       Date:  1992-12       Impact factor: 2.401

2.  Usual dietary salt intake and asthma in children: a case-control study.

Authors:  K Demissie; P Ernst; K Gray Donald; L Joseph
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

Review 3.  Airway smooth muscle relaxation.

Authors:  A J Knox; A E Tattersfield
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

4.  Partial inhibition by epithelium of tracheal smooth muscle relaxation induced by the potassium channel activator, BRL 38227.

Authors:  D Pavlovic; E Brione; D De Vernejoul; M Aubier
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  Bronchodilating effects of the novel potassium channel opener HOE 234 in human airways in vitro.

Authors:  M Miura; M G Belvisi; J K Ward; S Tadjkarimi; M H Yacoub; P J Barnes
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

6.  Effect of an oral potassium channel activator, BRL 38227, on airway function and responsiveness in asthmatic patients: comparison with oral salbutamol.

Authors:  J C Kidney; R W Fuller; Y M Worsdell; E A Lavender; K F Chung; P J Barnes
Journal:  Thorax       Date:  1993-02       Impact factor: 9.139

7.  Mechanism of action of a K+ channel activator BRL 38227 on ATP-sensitive K+ channels in mouse skeletal muscle fibres.

Authors:  M Hussain; A C Wareham; S I Head
Journal:  J Physiol       Date:  1994-08-01       Impact factor: 5.182

8.  In vitro and in silico studies of 8(17),12E,14-labdatrien-18-oic acid in airways smooth muscle relaxation: new molecular insights about its mechanism of action.

Authors:  Edilson B Alencar Filho; Luciano A A Ribeiro; Thiego G C Carvalho; Fabrício S Silva; Luiz Antonio M S Duarte-Filho; Euzébio G Barbosa; Pedro M N Menezes; Josean F Tavares; Marcelo S da Silva; Bagnólia A Silva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-18       Impact factor: 3.000

9.  Cromakalim inhibits transmitter acetylcholine release in rat trachea by an action on epithelial cells and a diffusible factor.

Authors:  Ross Vlahos; Maurice E Fabiani; David F Story
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-18       Impact factor: 3.000

10.  Regional and species differences in glyburide-sensitive K+ channels in airway smooth muscles as estimated from actions of KC 128 and levcromakalim.

Authors:  K Kamei; S Yoshida; J Imagawa; H Nabata; H Kuriyama
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.